SCHEMBL29979140

SCHEMBL29979140

CC1CCN(c2ccc(O)cc2N)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.64
GAA P10253 4/20 0.64
POLB P06746 2/20 0.64
HSD17B10 Q99714 2/20 0.64
NR4A1 P22736 1/20 0.64
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
USP2 O75604 1/20 0.60
ALDH1A1 P00352 8/20 0.59
MAPT P10636 3/20 0.59
HPGD P15428 3/20 0.59
NPC1 O15118 1/20 0.59
RAB9A P51151 1/20 0.59
HTT P42858 3/20 0.55
SMN1; SMN2 Q16637 2/20 0.44
CTPS1 P17812 1/20 0.44
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
RECQL P46063 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23043573 1.00 KDM4E (0.64) KDM4EGAAPOLBHSD17B10NR4A1
SCHEMBL7524892 0.84 ALDH1A1 (0.50) KDM4EGAAPOLBHSD17B10NR4A1
SCHEMBL30108222 0.83 ALDH1A1 (0.73) KDM4EGAAPOLBHSD17B10NR4A1
SCHEMBL29979173 0.81 GAA (0.62) KDM4EGAAPOLBHSD17B10NR4A1
SCHEMBL23043687 0.81 GAA (0.62) KDM4EGAAPOLBHSD17B10NR4A1
SCHEMBL8042381 0.80 KDM4E (0.60) KDM4EGAAPOLBHSD17B10NR4A1
SCHEMBL23043624 0.80 POLB (0.66) KDM4EGAAPOLBHSD17B10NR4A1
SCHEMBL29978698 0.80 POLB (0.66) KDM4EGAAPOLBHSD17B10NR4A1
SCHEMBL3073387 0.80 GAA (0.59) KDM4EGAAPOLBHSD17B10NR4A1
SCHEMBL13856584 0.78 KDM4E (1.00) KDM4EGAAPOLBHSD17B10NR4A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220315548-A1 SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES 2022-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220315548-A1 SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF MCOLN1, MCOLN2, MCOLN3 KDM4E 4671/4885GAA 154/4885POLB 3846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.